Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

SOHO State of the Art Updates and Next Questions | Novel Immunotherapy Combinations for the Treatment of Indolent B-Cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia(2025)10.1016/j.clml.2025.01.021Source: DataRank Database

SOHO State of the Art Updates and Next Questions | Novel Immunotherapy Combinations for the Treatment of Indolent B-Cell Lymphoma is a research paper published in Clinical Lymphoma Myeloma & Leukemia (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

3 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.44)OA: closedTopics (30)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Chen Zhang ORCID,Paolo Strati ORCID,Tony Zhuang ORCID

Live enrichment

PubMed:40011100 OpenAlex:https://openalex.org/W4406917127

National Institutes of Health

Grant: P30CA016672

Leukemia and Lymphoma Society

University of Texas MD Anderson Cancer Center

FWCI

2.44

Citation Percentile

0.9%

Citation Trend

2025

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S2152265025000369?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2152265025000369?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.clml.2025.01.021

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40011100

Fields of Study

Lymphoma Diagnosis and TreatmentChronic Lymphocytic Leukemia ResearchCAR-T cell therapy researchHumansImmunotherapyLymphoma, B-CellAntineoplastic Combined Chemotherapy Protocols

MeSH Terms

Antineoplastic Combined Chemotherapy ProtocolsHumansImmunotherapyLymphoma, B-Cell

Keywords

MedicineImmunotherapyLymphomaCancer researchState (computer science)B-cell lymphomaB cellOncologyInternal medicineDermatologyImmunologyCancerAntibodyProgramming languageFollicular LymphomaNon-hodgkin LymphomaBispecific AntibodiesBruton Tyrosine Kinase InhibitorsMosunetuzumab

Sustainable Development Goals

SDG 0: Zero hunger

SOHO State of the Art Updates and Next Questions | Novel Immunotherapy Combinations for the Treatment of Indolent B-Cell Lymphoma

FAIR Checklist

Authors (3)

Funding (3 grants)

Impact

Open Access

Topics